<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-290</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8481</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕВМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RHEUMATOLOGY</subject></subj-group></article-categories><title-group><article-title>Прогностическая ценность  гематологических индексов при системных воспалительных заболеваниях соединительной ткани</article-title><trans-title-group xml:lang="en"><trans-title>The prognostic value of hematological indices in systemic inflammatory diseases of connective tissue</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4087-3351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манзюк</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Manzyuk</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Манзюк Алексей Васильевич, ординатор, кафедра общей врачебной практики</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Aleksey V. Manzyuk, Resident, Department of General Medical Practice</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">aleksej-manzyuk@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3748-8180</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Морозова</surname><given-names>Т. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Morozova</surname><given-names>T. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Морозова Татьяна Евгеньевна, д.м.н., профессор, заведующая кафедрой общей врачебной практики</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Tatiana E. Morozova, Dr. Sci. (Med.), Professor, Head of the Department of General Medical Practice</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">morozova_t_e@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3324-5472</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герцог</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gertsog</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Герцог Анна Алексеевна, ассистент, кафедра общей врачебной практики</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Anna A. Gertsog, Assistant, Department of General Medical Practice</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">gertsog_a_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3136-2755</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Litvinova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Литвинова Мария Александровна, ассистент, кафедра внутренних, профессиональных болезней и ревматологии</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Mariia A. Litvinova, Assistant, Department of Internal Diseases, Occupational Diseases and Rheumatology</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">litvinova_m_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>15</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>12</issue><elocation-id>136–142</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Манзюк А.В., Морозова Т.Е., Герцог А.А., Литвинова М.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Манзюк А.В., Морозова Т.Е., Герцог А.А., Литвинова М.А.</copyright-holder><copyright-holder xml:lang="en">Manzyuk A.V., Morozova T.E., Gertsog A.A., Litvinova M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8481">https://www.med-sovet.pro/jour/article/view/8481</self-uri><abstract><sec><title>Введение</title><p>Введение. Отсутствие доступных и эффективных лабораторных маркеров делает прогнозирование обострений и прогрессирования при системных воспалительных заболеваниях соединительной ткани трудноразрешимой задачей для врачей-ревматологов и специалистов первичного звена, наблюдающих за пациентами. Гематологические индексы, рассчитываемые по общему анализу крови, продемонстрировали эффективность в прогнозировании течения ряда заболеваний.</p></sec><sec><title>Цель</title><p>Цель. Определить прогностическую ценность гематологических индексов общего анализа крови (RDW, MPV, PLR, NLR, LMR, PMR, PNR, SII) в прогнозировании обострений и прогрессирования системных воспалительных заболеваний соединительной ткани.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Для ретроспективного наблюдательного исследования по типу случай-контроль отбирались пациенты с системной красной волчанкой (СКВ) и АНЦА-ассоциированными васкулитами (микроскопический полиангиит, гранулематоз с полиангиитом, эозинофильный гранулематоз с полиангиитом). Пациенты с возникшим в течение 3–12 мес. обострением или прогрессированием заболевания определялись в основную группу, пациенты со стабильным заболеванием – в контрольную группу.</p></sec><sec><title>Результаты</title><p>Результаты. Было отобрано 60 пациентов, из которых у 25 в течение ближайших 3–12 мес. наблюдалось обострение или прогрессирование, 35 имели стабильное течение заболевания. Исходные клинико-демографические характеристики пациентов не имели значимых различий, в том числе между подгруппами с АНЦА-ассоциированными васкулитами (n = 35) и СКВ (n = 25). Пациенты в основной группе имели более высокую исходную ширину распределения эритроцитов (p &lt; 0,001). Между группами наблюдались статистически значимые отличия в исходном уровне тромбоцитарно-лимфоцитарного, нейтрофильно-лимфоцитарного, тромбоцитарно- ейтрофильного отношений и индекса системного воспаления, но в подгруппах СКВ и АНЦА-ассоциированных васкулитов отличия были разнонаправленными.</p></sec><sec><title>Заключение</title><p>Заключение. Ширина распределения эритроцитов демонстрировала более высокую прогностическую ценность в отношении обострений и прогрессирования АНЦА-ассоциированных васкулитов и СКВ по сравнению с СОЭ и С-РБ и представляется наиболее универсальной среди изучаемых маркеров прогноза системных воспалительных заболеваний соединительной ткани.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The lack of available and effective laboratory markers makes predicting exacerbations and progression in systemic inflammatory diseases of connective tissue an intractable task for rheumatologists and primary care specialists who monitor patients. Hematological indices calculated from a complete blood count have demonstrated effectiveness in predicting the course of several diseases.</p></sec><sec><title>Aim</title><p>Aim. To determine the prognostic value of hematological indices of complete blood count (RDW, MPV, PLR, NLR, LMR, PMR,</p><p>PNR, SII) in predicting exacerbations and progression of systemic inflammatory diseases of connective tissue</p></sec><sec><title>Materials and methods</title><p>Materials and methods. For a retrospective observational case-control study, patients with systemic lupus erythematosus (SLE) and ANCA-associated vasculitis (microscopic polyangiitis, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis) were selected. Patients with an exacerbation or progression of the disease that occurred within 3–12 months were assigned to the main group, patients with stable disease were assigned to the control group.</p></sec><sec><title>Results</title><p>Results. 60 patients were selected, of which 25 had an exacerbation or progression over the next 3–12 months, 35 had a stable course of the disease. The initial clinical and demographic characteristics of patients had no significant differences, including between the subgroups with ANCA-associated vasculitis (n = 35) and systemic lupus erythematosus (n = 25). Patients in the main group had a higher initial erythrocyte distribution width (p &lt; 0.001). Statistically significant differences were observed between the groups in the baseline level of platelet-lymphocytic, neutrophil-lymphocytic, platelet-neutrophil ratios and the index of systemic inflammation, but in the subgroups of SLE and ANCA-associated vasculitis, the differences were divergent.</p></sec><sec><title>Conclusion</title><p>Conclusion. The red blood cell distribution width demonstrated a higher prognostic value in relation to exacerbations and progression of ANCA-associated vasculitis and SLE compared with ESR and C-reactive protein and appears to be the most universal among the studied markers of prognosis of systemic inflammatory diseases of connective tissue.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эритроцитарные индексы</kwd><kwd>гематологический тест</kwd><kwd>системная красная волчанка</kwd><kwd>АНЦА-ассоциированный васкулит</kwd><kwd>прогностические маркеры</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>erythrocyte indices</kwd><kwd>hematological test</kwd><kwd>systemic lupus erythematosus</kwd><kwd>ANCA-associated vasculitis</kwd><kwd>prognostic markers</kwd><kwd>prognosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеева АС. Маркеры воспаления при ревматических заболеваниях. Научно-практическая ревматология. 2022;60(6):561–569. https://doi.org/10.47360/1995-4484-2022-561-569.</mixed-citation><mixed-citation xml:lang="en">Avdeeva AS. Inflammatory markers in rheumatic diseases. Rheumatology Science and Practice. 2022;60(6):561–569. (In Russ.) https://doi.org/10.47360/1995-4484-2022-561-569.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Александрова ЕН, Новиков АА, Насонов ЕЛ. Лабораторная диагностика ревматических заболеваний. Лабораторная служба. 2015;4(2):44–58. https://doi.org/10.17116/labs20154244-58.</mixed-citation><mixed-citation xml:lang="en">Aleksandrova EN, Novikov AA, Nasonov EL. Laboratory diagnosis of rheumatic diseases. Laboratory Service. 2015;4(2):44–58. (In Russ.) https://doi.org/10.17116/labs20154244-58.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine (Baltimore). 2018;97(39):e12342. https://doi.org/10.1097/MD.0000000000012342.</mixed-citation><mixed-citation xml:lang="en">Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine (Baltimore). 2018;97(39):e12342. https://doi.org/10.1097/MD.0000000000012342.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39(4):345–357. https://doi.org/10.3343/alm.2019.39.4.345.</mixed-citation><mixed-citation xml:lang="en">Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019;39(4):345–357. https://doi.org/10.3343/alm.2019.39.4.345.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W et al. Systemic immuneinflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. https://doi.org/10.1158/1078-0432.CCR-14-0442.</mixed-citation><mixed-citation xml:lang="en">Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W et al. Systemic immuneinflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–6222. https://doi.org/10.1158/1078-0432.CCR-14-0442 .</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chen JB, Tang R, Zhong Y, Zhou YO, Zuo X, Luo H et al. Systemic immune-inflammation index predicts a reduced risk of end-stage renal disease in Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated vasculitis: A retrospective observational study. Exp Ther Med. 2021;22(3):989. https://doi.org/10.3892/etm.2021.10421.</mixed-citation><mixed-citation xml:lang="en">Chen JB, Tang R, Zhong Y, Zhou YO, Zuo X, Luo H et al. Systemic immune-inflammation index predicts a reduced risk of end-stage renal disease in Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated vasculitis: A retrospective observational study. Exp Ther Med. 2021;22(3):989. https://doi.org/10.3892/etm.2021.10421.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hao X, Li D, Wu D, Zhang N. The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis. Sci Rep. 2017;7(1):10833. https://doi.org/10.1038/s41598-017-11398-4.</mixed-citation><mixed-citation xml:lang="en">Hao X, Li D, Wu D, Zhang N. The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis. Sci Rep. 2017;7(1):10833. https://doi.org/10.1038/s41598-017-11398-4.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57(4):1033–1038. https://doi.org/10.1007/s10620-011-1978-2.</mixed-citation><mixed-citation xml:lang="en">Song CS, Park DI, Yoon MY, Seok HS, Park JH, Kim HJ et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci. 2012;57(4):1033–1038. https://doi.org/10.1007/s10620-011-1978-2.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016;7(34):54564–54571. https://doi.org/10.18632/oncotarget.10515.</mixed-citation><mixed-citation xml:lang="en">Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016;7(34):54564–54571. https://doi.org/10.18632/oncotarget.10515.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P. Systemic immuneinflammatory index as a predictor of lymph node metastasis in endometrial cancer. J Inflamm Res. 2021;14:7131–7142. https://doi.org/10.2147/jir.S345790.</mixed-citation><mixed-citation xml:lang="en">Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P. Systemic immuneinflammatory index as a predictor of lymph node metastasis in endometrial cancer. J Inflamm Res. 2021;14:7131–7142. https://doi.org/10.2147/jir.S345790.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Demir M, Özbek M. A novel predictor in patients with coronary chronic total occlusion: systemic immune-inflammation index: a single-center cross-sectional study. Rev Assoc Med Bras (1992). 2022;68(5):579–585. https://doi.org/10.1590/1806-9282.20211097.</mixed-citation><mixed-citation xml:lang="en">Demir M, Özbek M. A novel predictor in patients with coronary chronic total occlusion: systemic immune-inflammation index: a single-center cross-sectional study. Rev Assoc Med Bras (1992). 2022;68(5):579–585. https://doi.org/10.1590/1806-9282.20211097.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li H, Zhou Y, Ma Y, Han S, Zhou L. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. Kardiol Pol. 2017;75(7):666–673. https://doi.org/10.5603/KP.a2017.0068.</mixed-citation><mixed-citation xml:lang="en">Li H, Zhou Y, Ma Y, Han S, Zhou L. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. Kardiol Pol. 2017;75(7):666–673. https://doi.org/10.5603/KP.a2017.0068.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Karaçalılar M, Demir M. A novel predictor in patients undergoing heart valve surgery: systemic inflammation response index: a single center cross-sectional study. Eur Rev Med Pharmacol Sci. 2023;27(3):1016–1022. https://doi.org/10.26355/eurrev_202302_31196.</mixed-citation><mixed-citation xml:lang="en">Karaçalılar M, Demir M. A novel predictor in patients undergoing heart valve surgery: systemic inflammation response index: a single center cross-sectional study. Eur Rev Med Pharmacol Sci. 2023;27(3):1016–1022. https://doi.org/10.26355/eurrev_202302_31196.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ et al. Clinical significance of preoperative neutrophil-lymphocyte versus plateletlymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17(3):216–222. https://doi.org/10.3109/1354750X.2012.656705.</mixed-citation><mixed-citation xml:lang="en">Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ et al. Clinical significance of preoperative neutrophil-lymphocyte versus plateletlymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17(3):216–222. https://doi.org/10.3109/1354750X.2012.656705.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ozisler C, Sandikci SC. Evaluation of red blood cell distribution width in patients with psoriatic arthritis. The Egyptian Rheumatologist. 2020;42(4):309–312. https://doi.org/10.1016/j.ejr.2019.06.001.</mixed-citation><mixed-citation xml:lang="en">Ozisler C, Sandikci SC. Evaluation of red blood cell distribution width in patients with psoriatic arthritis. The Egyptian Rheumatologist. 2020;42(4):309–312. https://doi.org/10.1016/j.ejr.2019.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fraenkel PG. Anemia of Inflammation: A Review. Med Clin North Am. 2017;101(2):285–296. https://doi.org/10.1016/j.mcna.2016.09.005.</mixed-citation><mixed-citation xml:lang="en">Fraenkel PG. Anemia of Inflammation: A Review. Med Clin North Am. 2017;101(2):285–296. https://doi.org/10.1016/j.mcna.2016.09.005.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50. https://doi.org/10.1182/blood-2018-06-856500.</mixed-citation><mixed-citation xml:lang="en">Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50. https://doi.org/10.1182/blood-2018-06-856500.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168(9):4620–4627. https://doi.org/10.4049/jimmunol.168.9.4620.</mixed-citation><mixed-citation xml:lang="en">Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168(9):4620–4627. https://doi.org/10.4049/jimmunol.168.9.4620.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tecer D, Sezgin M, Kanık A, İncel NA, Çimen ÖB, Biçer A, Şahin G. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med. 2016;10(9):967–974. https://doi.org/10.2217/bmm-2016-0148.</mixed-citation><mixed-citation xml:lang="en">Tecer D, Sezgin M, Kanık A, İncel NA, Çimen ÖB, Biçer A, Şahin G. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med. 2016;10(9):967–974. https://doi.org/10.2217/bmm-2016-0148.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hong J, Zhu B, Cai X, Liu S, Liu S, Zhu Q et al. Assessment of the association between red blood cell distribution width and disease activity in patients with systemic vasculitis. Exp Ther Med. 2021;22(1):691. https://doi.org/10.3892/etm.2021.10123.</mixed-citation><mixed-citation xml:lang="en">Hong J, Zhu B, Cai X, Liu S, Liu S, Zhu Q et al. Assessment of the association between red blood cell distribution width and disease activity in patients with systemic vasculitis. Exp Ther Med. 2021;22(1):691. https://doi.org/10.3892/etm.2021.10123.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Vayá A, Alis R, Hernández JL, Calvo J, Micó L, Romagnoli M, Ricarte JM. RDW in patients with systemic lupus erythematosus. Influence of anaemia and inflammatory markers. Clin Hemorheol Microcirc. 2013;54(3):333–339. https://doi.org/10.3233/CH-131738.</mixed-citation><mixed-citation xml:lang="en">Vayá A, Alis R, Hernández JL, Calvo J, Micó L, Romagnoli M, Ricarte JM. RDW in patients with systemic lupus erythematosus. Influence of anaemia and inflammatory markers. Clin Hemorheol Microcirc. 2013;54(3):333–339. https://doi.org/10.3233/CH-131738.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kim HJ, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis. Yonsei Med J. 2018;59(2):294–302. https://doi.org/10.3349/ymj.2018.59.2.294.</mixed-citation><mixed-citation xml:lang="en">Kim HJ, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis. Yonsei Med J. 2018;59(2):294–302. https://doi.org/10.3349/ymj.2018.59.2.294.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Horta-Baas G, Romero-Figueroa MDS. Clinical utility of red blood cell distribution width in inflammatory and non-inflammatory joint diseases. Int J Rheum Dis. 2019;22(1):47–54. https://doi.org/10.1111/1756-185X.13332.</mixed-citation><mixed-citation xml:lang="en">Horta-Baas G, Romero-Figueroa MDS. Clinical utility of red blood cell distribution width in inflammatory and non-inflammatory joint diseases. Int J Rheum Dis. 2019;22(1):47–54. https://doi.org/10.1111/1756-185X.13332.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Torres V, Castejón R, Mellor-Pita S, Tutor-Ureta P, Durán-Del Campo P, Martínez-Urbistondo M et al. Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus. J Transl Autoimmun. 2022;5:100157. https://doi.org/10.1016/j.jtauto.2022.100157.</mixed-citation><mixed-citation xml:lang="en">Moreno-Torres V, Castejón R, Mellor-Pita S, Tutor-Ureta P, Durán-Del Campo P, Martínez-Urbistondo M et al. Usefulness of the hemogram as a measure of clinical and serological activity in systemic lupus erythematosus. J Transl Autoimmun. 2022;5:100157. https://doi.org/10.1016/j.jtauto.2022.100157.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective. Mod Rheumatol. 2018;28(1):1–8. https://doi.org/10.1080/14397595.2017.1352477.</mixed-citation><mixed-citation xml:lang="en">Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective. Mod Rheumatol. 2018;28(1):1–8. https://doi.org/10.1080/14397595.2017.1352477.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bromberg L, Roufosse F, Pradier O, Delporte C, Van Antwerpen P, De Maertelaer V, Cogan E. Methylprednisolone-Induced Lymphocytosis in Patients with Immune-Mediated Inflammatory Disorders. Am J Med. 2016;129(7):746–752.e3. https://doi.org/10.1016/j.amjmed.2016.02.013.</mixed-citation><mixed-citation xml:lang="en">Bromberg L, Roufosse F, Pradier O, Delporte C, Van Antwerpen P, De Maertelaer V, Cogan E. Methylprednisolone-Induced Lymphocytosis in Patients with Immune-Mediated Inflammatory Disorders. Am J Med. 2016;129(7):746–752.e3. https://doi.org/10.1016/j.amjmed.2016.02.013.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hu ZD, Chen Y, Zhang L, Sun Y, Huang YL, Wang QQ et al. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Clin Chim Acta. 2013;425:202–205. https://doi.org/10.1016/j.cca.2013.08.007.</mixed-citation><mixed-citation xml:lang="en">Hu ZD, Chen Y, Zhang L, Sun Y, Huang YL, Wang QQ et al. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus. Clin Chim Acta. 2013;425:202–205. https://doi.org/10.1016/j.cca.2013.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Tatsi C, Boden R, Sinaii N, Keil M, Lyssikatos C, Belyavskaya E et al. Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome. Pediatr Res. 2018;83(2):431–437. https://doi.org/10.1038/pr.2017.278.</mixed-citation><mixed-citation xml:lang="en">Tatsi C, Boden R, Sinaii N, Keil M, Lyssikatos C, Belyavskaya E et al. Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome. Pediatr Res. 2018;83(2):431–437. https://doi.org/10.1038/pr.2017.278.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Crawford VL, McNerlan SE, Stout RW. Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing. 2003;32(6):661–665. https://doi.org/10.1093/ageing/afg113.</mixed-citation><mixed-citation xml:lang="en">Crawford VL, McNerlan SE, Stout RW. Seasonal changes in platelets, fibrinogen and factor VII in elderly people. Age Ageing. 2003;32(6):661–665. https://doi.org/10.1093/ageing/afg113.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Subhashree AR, Parameaswari PJ, Shanthi B, Revathy C, Parijatham BO. The reference intervals for the haematological parameters in healthy adult population of Chennai, Southern India. J Clin Diagn Res. 2012;6(10):1675–1680. https://doi.org/10.7860/JCDR/2012/4882.2630.</mixed-citation><mixed-citation xml:lang="en">Subhashree AR, Parameaswari PJ, Shanthi B, Revathy C, Parijatham BO. The reference intervals for the haematological parameters in healthy adult population of Chennai, Southern India. J Clin Diagn Res. 2012;6(10):1675–1680. https://doi.org/10.7860/JCDR/2012/4882.2630.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
